CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD is undergoing clinical studies, Cubist Pharmaceuticals, Inc announced.
Indian generic major Sun Pharma has will market generic bupropion (Wellbutrin SR) in US soon.
Jaiva Technologies will organize clinical trials of Radient Pharmaceuticals's cancer vaccine in India.
Indian government has suspended Merck's cervical cancer vaccine Gardasil study in two states following reports of deaths of 4 girls and several complications.
Indian firm Cipla Ltd is planning to sell the generic version of kidney cancer drug sorafenib (Nexavar) at one tenth of Bayer's selling price in India pending court case.